Thermo Fisher Scientific’s pharma services provide end-to-end contract development and manufacturing (CDMO) solutions that support pharmaceutical and biotech companies across the entire drug lifecycle—from early development to commercial production. Its integrated offerings span drug substances and drug products for both small and large molecules, along with clinical trial services, supply chain, and commercial manufacturing, all delivered through a global network of facilities and scientific expertise to help move therapies from molecule to market efficiently.
Thermo Fisher’s oral solid dose (OSD) services focus on the development and manufacturing of tablets, capsules, and related oral formulations, the most common drug delivery form due to stability and patient compliance. The company offers integrated capabilities from early formulation development and process optimization through scale-up and commercial manufacturing, supporting a wide range of simple or complex formulations, immediate-release and modified-release dosage forms, and packaging solutions, all backed by advanced technologies, global GMP facilities, and strong regulatory experience.